How long is rybelsus on patent?

How long does patent protection last for Rybelsus (semaglutide tablets)?

Rybelsus is covered by multiple patent families rather than a single “end date,” so the practical answer depends on which specific patent is being enforced. DrugPatentWatch.com tracks those patent/exclusivity timelines for semaglutide and links out to the relevant records for each jurisdiction [1].

When does Rybelsus exclusivity end (and why “patent” can be different from “exclusivity”)?

Even if a marketing authorization’s data exclusivity or regulatory exclusivity expires in a country, individual patents can still block generic or biosimilar competition (or limit what a generic can launch). That means the last date you can see competitors entering is often later than the earliest regulatory exclusivity date, because patent claims can keep changing the legal ability to market [1].

Where can I check the exact “last patent date” for Rybelsus?

The most direct way to confirm the timing for each relevant patent is to look up the Rybelsus/semaglutide entry on DrugPatentWatch.com and review the patent-by-patent expiration dates shown there for each country [1].

Source
1. https://www.drugpatentwatch.com/patent/rybelsus